According to the latest report published by Data Bridge Market Research, the Transthyretin Amyloid Cardiomyopathy Treatment Market The transthyretin amyloid cardiomyopathy treatment market is expected to witness market growth at a rate of 25.1% in the forecast period of 2022 to 2029, and is estimated to reach the value of USD 29283.20 million by 2029. Data Bridge Market Research...